PL357427A1 - Method of manufacture of crystalline form of methyl 1 hydrogen sulphate (+)-(s)-alpha- (2-chlorophenylo)-4,5,6,7-tetra hydrotieno[3,2-c]pirydynylo-5-acetate
- Google Patents
Method of manufacture of crystalline form of methyl 1 hydrogen sulphate (+)-(s)-alpha- (2-chlorophenylo)-4,5,6,7-tetra hydrotieno[3,2-c]pirydynylo-5-acetate
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANPHARM Przedsiębiorstwo Farmaceutyczne SAfiledCriticalANPHARM Przedsiębiorstwo Farmaceutyczne SA
Priority to PL357427ApriorityCriticalpatent/PL203408B1/en
Priority claimed from PL357427Aexternal-prioritypatent/PL203408B1/en
Publication of PL357427A1publicationCriticalpatent/PL357427A1/en
Publication of PL203408B1publicationCriticalpatent/PL203408B1/en
PL357427A2002-11-28
Method for the preparation of crystal form 1 of methyl (+) - (S) - a- (2-chlorophenyl) -4,5,6,7-tetrahydrothieno [3,2-c] pyridinyl-5-acetate
PL203408B1
(en)
Method of manufacture of crystalline form of methyl 1 hydrogen sulphate (+)-(s)-alpha- (2-chlorophenylo)-4,5,6,7-tetra hydrotieno[3,2-c]pirydynylo-5-acetate